Side Effects of Fluconazole
Fluconazole commonly causes headache, nausea, abdominal pain, diarrhea, and dizziness, with more serious adverse effects including hepatotoxicity, QT prolongation, and allergic reactions occurring less frequently. 1
Common Side Effects
Fluconazole is generally well tolerated, but several side effects may occur:
- Most common side effects (1-5% of patients):
- Headache (13% in single-dose therapy for vaginal candidiasis)
- Nausea (7% in single-dose therapy)
- Abdominal pain (6% in single-dose therapy)
- Diarrhea (3% in single-dose therapy, 1.5% in multi-dose therapy)
- Dizziness (1%)
- Taste perversion (1%)
- Vomiting (1.7% in multi-dose therapy)
- Skin rash (1.8% in multi-dose therapy) 1
Serious Adverse Effects
Hepatobiliary Effects
- Hepatotoxicity: Rare but serious hepatic reactions ranging from mild transaminase elevations to fulminant hepatic failure and death
- Risk factors for hepatotoxicity include:
- AIDS or malignancy
- Concomitant hepatotoxic medications
- Multiple medications 1
Cardiovascular Effects
- QT prolongation and torsade de pointes (rare but potentially fatal) 1
- Avoid in patients with pre-existing cardiac conditions or those taking other QT-prolonging medications 2
Immunologic/Dermatologic Reactions
- Serious allergic reactions including anaphylaxis, angioedema, face edema, and pruritus (rare)
- Serious skin reactions that can be life-threatening in patients with serious underlying conditions 1
Endocrine Effects
- Adrenal insufficiency (reversible): Presents with fatigue, muscle weakness, loss of appetite, weight loss, stomach pain, dizziness, nausea, and vomiting 1
Long-Term Therapy Side Effects
With prolonged use (particularly relevant for antifungal prophylaxis or treatment of systemic mycoses):
- Xerosis (dry skin) (16.9%)
- Alopecia (hair loss) (16.1%)
- Fatigue (11.3%)
- Approximately 65.6% of patients on long-term therapy may require dose reduction, discontinuation, or switch to another antifungal due to adverse effects 3
Drug Interactions
Fluconazole has substantial drug interactions due to inhibition of cytochrome P450 enzymes:
- Warfarin: Increased anticoagulant effect requiring dose adjustment
- Oral hypoglycemics: Enhanced hypoglycemic effects
- Phenytoin: Increased phenytoin levels and toxicity
- Cyclosporine: Increased immunosuppressant levels
- Rifampin: May decrease fluconazole levels
- Statins: Increased risk of myopathy and rhabdomyolysis
- Opioids: Significantly increases oxycodone plasma concentrations 2, 1
Special Populations
Pregnancy
- Fluconazole is teratogenic at high doses in animal studies
- Cases of craniofacial and skeletal defects have been reported after prolonged use at high doses in the first trimester
- Single-dose treatment in the first trimester has not been associated with increased anomalies 4
Renal Impairment
- Dosage adjustment required due to primarily renal elimination
- Increased risk of toxicity without appropriate dose reduction 1
Elderly
- More susceptible to adverse effects due to age-related changes in drug metabolism 2
Monitoring Recommendations
- Baseline liver function tests before initiating therapy
- Periodic monitoring of liver function during treatment, especially for prolonged courses
- Discontinue fluconazole if signs of liver injury develop (jaundice, dark urine, light-colored stools, severe itching, fatigue, loss of appetite)
- Monitor for drug interactions when starting or stopping fluconazole, as effects may persist for 4-5 days after discontinuation 2, 1
Fluconazole's side effect profile should be carefully considered when selecting antifungal therapy, particularly for patients with underlying liver disease, cardiac conditions, or those taking multiple medications with potential interactions.